Literature DB >> 18590359

Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.

Susan De Santi1, Elizabeth Pirraglia, William Barr, James Babb, Schantel Williams, Kimberley Rogers, Lidia Glodzik, Miroslaw Brys, Lisa Mosconi, Barry Reisberg, Steven Ferris, Mony J de Leon.   

Abstract

The aim of the study was to compare the performance of Robust and Conventional neuropsychological norms in predicting clinical decline among healthy adults and in mild cognitive impairment (MCI). The authors developed Robust baseline cross sectional and longitudinal change norms from 113 healthy participants retaining a normal diagnosis for at least 4 years. Baseline Conventional norms were separately created for 256 similar healthy participants without follow-up. Conventional and Robust norms were tested in an independent cohort of longitudinally studied healthy (n=223), MCI (n=136), and Alzheimer's disease (AD, n=162) participants; 84 healthy participants declined to MCI or AD (NL-->DEC), and 44 MCI declined to AD (MCI-->AD). Compared to Conventional norms, baseline Robust norms correctly identified a higher proportion of NL-->DEC with impairment in delayed memory and attention-language domains. Both norms predicted decline from MCI-->AD. Change norms for delayed memory and attention-language significantly incremented baseline classification accuracies. These findings indicate that Robust norms improve identification of healthy individuals who will decline and may be useful for selecting at-risk participants for research studies and early interventions. PsycINFO Database Record (c) 2008 APA, all rights reserved.

Entities:  

Mesh:

Year:  2008        PMID: 18590359      PMCID: PMC2661242          DOI: 10.1037/0894-4105.22.4.469

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  72 in total

1.  Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

Authors:  A Convit; M J De Leon; C Tarshish; S De Santi; W Tsui; H Rusinek; A George
Journal:  Neurobiol Aging       Date:  1997 Mar-Apr       Impact factor: 4.673

2.  Hippocampal hypometabolism predicts cognitive decline from normal aging.

Authors:  Lisa Mosconi; Susan De Santi; Juan Li; Wai Hon Tsui; Yi Li; Madhu Boppana; Eugene Laska; Henry Rusinek; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2007-01-11       Impact factor: 4.673

3.  Normative data stratified for age, education, and gender on the Boston Naming Test.

Authors:  Ronald F Zec; Nicole R Burkett; Stephen J Markwell; Deb L Larsen
Journal:  Clin Neuropsychol       Date:  2007-07       Impact factor: 3.535

4.  Brief Cognitive Rating Scale (BCRS).

Authors:  B Reisberg; S H Ferris
Journal:  Psychopharmacol Bull       Date:  1988

5.  Operationalizing memory impairment for elderly persons: the Guild Memory Test.

Authors:  T Crook; J G Gilbert; S Ferris
Journal:  Psychol Rep       Date:  1980-12

6.  Neuropsychological assesment of psychogeriatric patients with limited education.

Authors:  B A Marcopulos; D L Gripshover; D K Broshek; C A McLain; H R Brashear
Journal:  Clin Neuropsychol       Date:  1999-05       Impact factor: 3.535

7.  Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults.

Authors:  J D Flory; S B Manuck; R E Ferrell; C M Ryan; M F Muldoon
Journal:  Am J Med Genet       Date:  2000-12-04

8.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

9.  Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals.

Authors:  Dorene M Rentz; Terri J Huh; Robert R Faust; Andrew E Budson; Leonard F M Scinto; Reisa A Sperling; Kirk R Daffner
Journal:  Neuropsychology       Date:  2004-01       Impact factor: 3.295

10.  Brain imaging evidence of preclinical Alzheimer's disease in normal aging.

Authors:  William Jagust; Amy Gitcho; Felice Sun; Beth Kuczynski; Dan Mungas; Mary Haan
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

View more
  46 in total

1.  Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease.

Authors:  Lisa Mosconi; Wai Tsui; John Murray; Pauline McHugh; Yi Li; Schantel Williams; Elizabeth Pirraglia; Lidia Glodzik; Susan De Santi; Shankar Vallabhajosula; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2011-04-22       Impact factor: 4.673

2.  Structural brain changes in normal individuals with a maternal history of Alzheimer's.

Authors:  Valentina Berti; Lisa Mosconi; Lidia Glodzik; Yi Li; John Murray; Susan De Santi; Alberto Pupi; Wai Tsui; Mony J De Leon
Journal:  Neurobiol Aging       Date:  2011-02-12       Impact factor: 4.673

3.  Peri-Operative Inflammatory Cytokines in Plasma of the Elderly Correlate in Prospective Study with Postoperative Changes in Cognitive Test Scores.

Authors:  R Kline; E Wong; M Haile; S Didehvar; S Farber; A Sacks; E Pirraglia; M J de Leon; A Bekker
Journal:  Int J Anesthesiol Res       Date:  2016-08-16

Review 4.  Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.

Authors:  Kaj Blennow; Bruno Dubois; Anne M Fagan; Piotr Lewczuk; Mony J de Leon; Harald Hampel
Journal:  Alzheimers Dement       Date:  2014-05-03       Impact factor: 21.566

5.  Periodontal disease associates with higher brain amyloid load in normal elderly.

Authors:  Angela R Kamer; Elizabeth Pirraglia; Wai Tsui; Henry Rusinek; Shankar Vallabhajosula; Lisa Mosconi; Li Yi; Pauline McHugh; Ronald G Craig; Spencer Svetcov; Ross Linker; Chen Shi; Lidia Glodzik; Schantel Williams; Patricia Corby; Deepak Saxena; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2014-11-05       Impact factor: 4.673

6.  Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention.

Authors:  Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager
Journal:  Dement Geriatr Cogn Disord       Date:  2014-02-20       Impact factor: 2.959

7.  Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.

Authors:  Ricardo S Osorio; Indu Ayappa; Janna Mantua; Tyler Gumb; Andrew Varga; Anne M Mooney; Omar E Burschtin; Zachary Taxin; Emmanuel During; Nicole Spector; Milton Biagioni; Elizabeth Pirraglia; Hiuyan Lau; Henrik Zetterberg; Kaj Blennow; Shou-En Lu; Lisa Mosconi; Lidia Glodzik; David M Rapoport; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

8.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.

Authors:  Lisa Mosconi; Rachel Mistur; Remigiusz Switalski; Wai Hon Tsui; Lidia Glodzik; Yi Li; Elizabeth Pirraglia; Susan De Santi; Barry Reisberg; Thomas Wisniewski; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-14       Impact factor: 9.236

9.  Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.

Authors:  Ricardo S Osorio; Emma L Ducca; Margaret E Wohlleber; Emily B Tanzi; Tyler Gumb; Akosua Twumasi; Samuel Tweardy; Clifton Lewis; Esther Fischer; Viachaslau Koushyk; Maria Cuartero-Toledo; Mohammed O Sheikh; Elizabeth Pirraglia; Henrik Zetterberg; Kaj Blennow; Shou-En Lu; Lisa Mosconi; Lidia Glodzik; Sonja Schuetz; Andrew W Varga; Indu Ayappa; David M Rapoport; Mony J de Leon
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

10.  Mild Cognitive Impairment in Late Middle Age in the Wisconsin Registry for Alzheimer's Prevention Study: Prevalence and Characteristics Using Robust and Standard Neuropsychological Normative Data.

Authors:  Lindsay R Clark; Rebecca L Koscik; Christopher R Nicholas; Ozioma C Okonkwo; Corinne D Engelman; Lisa C Bratzke; Kirk J Hogan; Kimberly D Mueller; Barbara B Bendlin; Cynthia M Carlsson; Sanjay Asthana; Mark A Sager; Bruce P Hermann; Sterling C Johnson
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.